Cara Therapeutics

+$0.23 (+2.87%) Today
+$0.26 (+3.16%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.

CEO
Christopher Posner
Employees
84
Headquarters
Stamford, Connecticut
Founded
2004

CARA Key Statistics

Market cap
441.59M
Price-Earnings ratio
—
Dividend yield
—
Average volume
556.45K
High today
$8.29
Low today
$7.89
Open price
$8.16
Volume
281.94K
52 Week high
$18.93
52 Week low
$7.40

CARA News

Simply Wall StMay 23

What Type Of Shareholders Own The Most Number of Cara Therapeutics, Inc. Shares? - Yahoo Finance

A look at the shareholders of Cara Therapeutics, Inc. (NASDAQ:CARA) can tell us which group is most powerful. Institutions will often hold stock in bigger compa

CARA Earnings

-$0.63
$0.11
$0.85
$1.59
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure